NCT06913101View on ClinicalTrials.gov

Comparison of Once-Weekly Trelagliptin vs. Once-Daily Vildagliptin for HbA1c Reduction in Type 2 Diabetes

NAActive, not recruitingINTERVENTIONAL

Enrollment

102

Participants

Timeline

Start Date

November 15, 2024

Primary Completion Date

May 15, 2025

Study Completion Date

May 15, 2025

Conditions

Type 2 Diabetes Mellitus (T2DM)

Interventions

DRUG

Trelagliptin 100 mg

Trelagliptin 100 mg was administered orally once weekly before breakfast on the same day of the week.

DRUG

Vildagliptin 50 mg

Vildagliptin 50 mg was administered orally once daily.

Trial Locations (1)

44000

PNS Hafeez - Naval Hospital, Islamabad

All Listed Sponsors

lead

PNS Hafeez - Naval Hospital

OTHER_GOV

NCT06913101 - Comparison of Once-Weekly Trelagliptin vs. Once-Daily Vildagliptin for HbA1c Reduction in Type 2 Diabetes | Biotech Hunter | Biotech Hunter